CAMPANI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.903
EU - Europa 1.474
AS - Asia 466
AF - Africa 15
OC - Oceania 3
Totale 3.861
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.895
RU - Federazione Russa 780
IT - Italia 299
IE - Irlanda 143
HK - Hong Kong 139
SG - Singapore 133
CN - Cina 108
SE - Svezia 80
PL - Polonia 53
JO - Giordania 35
FI - Finlandia 33
IN - India 30
GB - Regno Unito 26
FR - Francia 23
CI - Costa d'Avorio 10
DE - Germania 10
NL - Olanda 10
RO - Romania 9
CA - Canada 8
KR - Corea 6
EG - Egitto 4
UA - Ucraina 4
VN - Vietnam 4
AU - Australia 3
BD - Bangladesh 2
CH - Svizzera 2
JP - Giappone 2
NP - Nepal 2
TW - Taiwan 2
AM - Armenia 1
BE - Belgio 1
ID - Indonesia 1
LT - Lituania 1
TJ - Tagikistan 1
TZ - Tanzania 1
Totale 3.861
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.020
Dublin 143
Singapore 120
Hong Kong 99
Ashburn 97
Chandler 71
Fairfield 69
Florence 59
Warsaw 52
Moscow 51
Lawrence 41
Altamura 40
Shanghai 34
Houston 32
Cambridge 28
Helsinki 28
Beijing 26
Kent 24
Woodbridge 24
Arezzo 22
Princeton 22
Wilmington 22
Buffalo 21
Milan 20
Mumbai 20
Seattle 19
Boston 18
Rome 16
Bologna 14
New York 14
West Jordan 14
Los Angeles 12
Paris 12
Abidjan 10
San Diego 10
Ann Arbor 9
London 9
Timisoara 9
Medford 7
Hangzhou 6
Toronto 6
Lappeenranta 5
Pune 5
Seoul 5
Washington 5
Bari 4
Dong Ket 4
Fort Worth 4
Modena 4
Scandicci 4
Yubileyny 4
Boardman 3
Cagliari 3
Fontebuona 3
Menlo Park 3
Palermo 3
Perugia 3
Prato 3
Romola 3
Villaricca 3
Acerra 2
Acton 2
Albino 2
Amsterdam 2
Ancona 2
Aosta 2
Bern 2
Brescia 2
Cairo 2
Caserta 2
Castelli Calepio 2
Central 2
Cerro al Volturno 2
Chennai 2
Chiswick 2
Dhaka 2
Falls Church 2
Genoa 2
Hillsboro 2
Kathmandu 2
Lodi 2
Lucca 2
Manchester 2
Montepulciano 2
Munich 2
Osimo 2
Ottawa 2
Perth 2
Pisa 2
Prescot 2
Redwood City 2
Rennes 2
Romainville 2
Saint-Fons 2
San Antonio 2
Silea 2
Southwark 2
Spoleto 2
Springfield 2
Stevenage 2
Totale 2.521
Salva come PNG Salva come JPEG
Nome #
A large rheumatoid nodule mimicking hepatic malignancy 146
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 128
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives 126
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 114
Long-term efficacy and safety of vedolizumab in patients with inflammatory bowel diseases: A real-life experience from a tertiary referral center 109
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma 105
CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib 102
Prevalence of nutritional risk and malnutrition during and after hospitalization for COVID-19 infection: Preliminary results of a single-centre experience 88
Dynamics of endothelial progenitor cells in patients with advanced hepatocellular carcinoma 87
Time-varying mHAP III is the most accurate predictor of survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization 84
Angiogenesis inhibitors for advanced hepatocellular carcinoma: in search for the right partner 83
Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis 82
Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectives 81
Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey 81
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 81
Circulating biomarkers of response to systemic treatments in advanced hepatocellular 80
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma 80
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 80
Pattern of macrovascular invasion in hepatocellular carcinoma 79
The changing scenario of hepatocellular carcinoma in Italy: an update 76
Practical insights into chronic management of hepatic Wilson's disease 74
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 73
Lenvatinib: established and promising drug for the treatment of advanced hepatocellular carcinoma 73
Biological therapies in patients with liver disease: are they really lifesavers? 73
Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes 67
Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients 67
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 66
Needs evaluation questionnaire for liver disease: a novel assessment of unmet needs in patients with chronic liver disease 65
Metabolic disorders across hepatocellular carcinoma in Italy 63
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted Comparison 63
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib 61
Statin-induced, immune-mediated injury with simultaneous targeting of skeletal muscle, skin and liver 60
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy 60
Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study 56
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 54
Main factors influencing long-term outcomes of liver transplantation in 2022 54
Quick and easy assessment of sarcopenia in cirrhosis: Can ultrasound be the solution? 53
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 51
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs 51
Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice 51
Fragility index of positive phase II and III randomized clinical trials of treatments for hepatocellular carcinoma (2002-2022) 48
An atypical case of palmo-plantar erythrodysesthesia related to cabozantinib 47
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma 46
Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA 44
Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab 44
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study 43
Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab-bevacizumab 41
Systemic treatment of hepatocellular carcinoma: the times they are a-changin' 40
Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC 40
Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients 38
No correlation between MASLD and poor outcome of Atezolizumab‐Bevacizumab therapy in patients with advanced HCC 38
Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab 37
Elusive Hepatic Nodules 36
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment 35
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib 31
Probiotics and the gut-liver axis 30
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care 30
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma 28
Incidence and Predictors of Esophagogastric Varices Bleeding in Patients with Hepatocellular Carcinoma in Lenvatinib 27
The upward trajectory of the UEG journal: Next Generation Trainee Editors 27
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors 27
Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab 23
Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 22
null 2
Totale 3.951
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.205
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.205
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202054 0 0 0 0 0 4 7 10 8 12 10 3
2020/2021162 6 14 6 11 4 11 28 28 19 14 12 9
2021/2022194 15 1 7 2 2 13 0 10 31 34 32 47
2022/2023586 36 111 31 8 27 109 83 43 70 31 28 9
2023/2024669 23 39 56 18 35 71 42 198 26 71 58 32
2024/20252.261 98 310 178 447 851 377 0 0 0 0 0 0
Totale 3.951